© 2023 MJH Life Sciences and Drug Topics. All rights reserved.
© 2023 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 17, 2023
A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.
January 11, 2023
Pharmacists can play an important role in patients’ wellness journeys.
December 20, 2022
Pradaxa (dabigatran) and Coumadin (warfarin) came out even in this randomized study. The Brazilian researchers who conducted the study said one explanation for the result is that use of Coumadin was exceptionally well managed because the patients were enrolled a study.
November 22, 2022
Mount Sinai study is the first to identify that heart attack, stroke and heart failure are linked to a specific type of age-related macular degeneration.
November 11, 2022
According to a study, use is linked to a lower prevalence of age-related macular degeneration in European populations.
October 17, 2022
US Preventive Services Task Force hasn't endorsed screening for atrial fibrillation. Findings from these two studies might factor into a reconsideration.
October 11, 2022
Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.
August 29, 2022
New research looks at the potential benefits of long-term statin use in patients who are at increased risk of cardiovascular disease.
August 24, 2022
Used to treat a variety of concerns and found in many medicine cabinets, new research indicates that nonsteroidal anti-inflammatory drugs may pose a risk to patients with type 2 diabetes.
August 22, 2022
Lack of blood clotting may afford some protection against common cardiovascular disease events, such as ischemic stroke.